Protective efficacy of an AIDS vaccine, a single DNA priming followed by a single booster with a recombinant replication-defective Sendai virus vector, in a macaque AIDS model

J Virol. 2003 Sep;77(17):9710-5. doi: 10.1128/jvi.77.17.9710-9715.2003.

Abstract

We previously demonstrated the excellent protective efficacy of DNA priming followed by Gag-expressing Sendai virus (SeV) boosting (DNA prime/SeV-Gag boost vaccine) against a pathogenic simian-human immunodeficiency virus (SHIV89.6PD) infection in macaques. Here we show that we established a practical, safer AIDS vaccine protocol, a single DNA priming followed by a single booster with a recently developed replication-defective F deletion SeV-expressing Gag, and show its protective efficacy against SHIV89.6PD infections.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AIDS Vaccines / administration & dosage*
  • AIDS Vaccines / genetics
  • Acquired Immunodeficiency Syndrome / immunology
  • Acquired Immunodeficiency Syndrome / prevention & control
  • Animals
  • CD4-Positive T-Lymphocytes / immunology
  • CD8-Positive T-Lymphocytes / immunology
  • DNA, Viral / administration & dosage*
  • DNA, Viral / genetics
  • Defective Viruses / genetics
  • Disease Models, Animal
  • Genes, gag
  • Genetic Vectors
  • Humans
  • Immunization, Secondary
  • Macaca fascicularis
  • Macaca mulatta
  • SAIDS Vaccines / administration & dosage
  • SAIDS Vaccines / genetics
  • Sendai virus / genetics
  • Simian Acquired Immunodeficiency Syndrome / immunology
  • Simian Acquired Immunodeficiency Syndrome / prevention & control
  • Vaccines, DNA / administration & dosage*
  • Vaccines, DNA / genetics

Substances

  • AIDS Vaccines
  • DNA, Viral
  • SAIDS Vaccines
  • Vaccines, DNA